Akebia Therapeutics Forecast and Stock Analysis
Technical AKBA stock analysis for March 22, 2019.
Akebia Therapeutics fell by -3.56% in the last day from $8.70 to $8.39 The price has risen in 5 of the last 10 days and is up by 19.35% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -0.09 million shares and in total 1.24 million shares bought and sold for approximately $10.39 million.
Close price at the end of the last trading day (Friday, 22nd Mar 2019) of the AKBA stock was $8.39. This is 3.56% less than the trading day before Thursday, 21st Mar 2019.
During day the stock fluctuated 7.04% from a day low at $8.38 to a day high of $8.97.
30 day high of the AKBA stock price was $9.30 and low was $6.42.
90 day high was $9.30 and low was $5.20.
52 week high for the Akebia Therapeutics - $11.60 and low - $5.20.
Akebia Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 42.74% during the next 3 months and, with 90% probability hold a price between $9.87 and $12.64 at the end of this period.
Akebia Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $8.30 and $7.14. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Thursday March 21, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSI14 is 67 and the stock is currently not being overbought or oversold
Support & Resistance
Akebia Therapeutics finds support from accumulated volume at $8.17.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.59 between high and low, or 7.04%. For the last week, the stock has had a daily average volatility of 7.86%.
Our recommended stoploss: $7.91 (-5.76%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from pivot top found 1 days ago.)
Very Low Low Medium High Very High
Evaluation: Buy Candidate
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.